




Searching News Database: Resonate
HSMN NewsFeed - 9 May 2022
BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder (OAB) Treatment
BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder (OAB) Treatment
HSMN NewsFeed - 17 Jan 2022
CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation
CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation
HSMN NewsFeed - 3 Feb 2020
Eisai Inc. Expands Leadership Team in the US with the Appointment of Two Key Leaders
Eisai Inc. Expands Leadership Team in the US with the Appointment of Two Key Leaders
HSMN NewsFeed - 9 May 2017
Boston Scientific Receives U.S. FDA Approval For Resonate(TM) Family Of High-Voltage Devices
Boston Scientific Receives U.S. FDA Approval For Resonate(TM) Family Of High-Voltage Devices
HSMN NewsFeed - 3 Mar 2017
Cardiome Announces Commercial Launch of Xydalba(TM) (dalbavancin) in France
Cardiome Announces Commercial Launch of Xydalba(TM) (dalbavancin) in France
HSMN NewsFeed - 8 Dec 2016
Cardiome Announces Commercial Launch of Xydalba(TM) (dalbavancin) in the UK
Cardiome Announces Commercial Launch of Xydalba(TM) (dalbavancin) in the UK
HSMN NewsFeed - 7 Jul 2009
Luminetx(R) Ends First Half with Continued Global Expansion and Key Milestone Achieved
Luminetx(R) Ends First Half with Continued Global Expansion and Key Milestone Achieved
HSMN NewsFeed - 27 Sep 2007
Central Texas Health System Strengthens Processes for Contracting Through Premier's Breakthrough Series
Central Texas Health System Strengthens Processes for Contracting Through Premier's Breakthrough Series
Additional items found! 6

Members Archive contains
6 additional stories matching:
Resonate
(Password required)
Resonate
(Password required)